Navigation Links
Valeant Pharmaceuticals Files Presentation for Cephalon Stockholders
Date:4/11/2011

ing untested biotech products departs dramatically from Cephalon's historical focus of marketing products other companies have primarily developed and taken through the regulatory process.
  • Cephalon is not a high-growth biotechnology company.  Provigil, which accounted for approximately 41% of its net sales in fiscal year 2010, will face generic competition next year.  Based on IBES consensus equity research estimates, from 2011-2013, Cephalon's revenues and EPS are expected to fall by 20% and 42%, respectively.
  • Cephalon's share price performance prior to Valeant's offer reflected its declining fundamental value. Repeated pipeline failures and an inability to fill the impending loss of Provigil have negatively impacted Cephalon's valuation.  In fact, Cephalon's 52-week high was following rumors of a sale process and dropped off sharply after Cephalon was unable to attain approval for Nuvigil for the treatment of jet lag.  Concern over Cephalon's business model was demonstrated by 68% of Wall Street analysts having ratings equivalent to "sell" or "hold" prior to Valeant's offer.
  • Valeant's offer represents a full and fair premium. Valeant's $73 per share all cash offer represents a 29% premium to Cephalon's 30-day trading average at announcement.  The median premium to 30-day trading averages in all U.S. acquisitions since 2006 was 25%, and 60% of those acquisitions were completed at a premium of less than 30% to 30-day trading averages.  In addition, Valeant's offer already accounts for the substantial value leakage due to change of control costs for Cephalon's convertible debt and call spread.

  • Timing is critical to Valeant.  Wall Street analysts project Cephalon's earnings to decline by more than 40% after Provigil loses patent protection in 2012.  Cephalon's value to Valeant erodes each day Valeant is delayed in implementing its business strategy as Provi
    '/>"/>

    SOURCE Valeant Pharmaceuticals International, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Valeant Pharmaceuticals Files Preliminary Consent Solicitation Statement With the SEC
    2. Promius Pharma and Valeant Form Collaboration to Market Cloderm® Cream in the United States
    3. Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash
    4. GSK and Valeant Receive European Authorisation for Trobalt (retigabine)
    5. Valeant Pharmaceuticals Extends Contract with J. Michael Pearson as CEO and Appoints Him as Chairman of the Board
    6. Valeant Pharmaceuticals Completes Acquisition of PharmaSwiss S.A.
    7. Valeant Announces Pricing of Senior Notes
    8. Valeant Launches Senior Notes Offering
    9. Valeant Pharmaceuticals to Present at RBC Capital Markets 2011 Healthcare Conference
    10. Valeant Pharmaceuticals to Announce 2010 Fourth Quarter and Full Year Results on February 24, 2011
    11. Valeant Pharmaceuticals Announces License Of ACZONE® (dapsone) Gel 5% In Canada
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/30/2014)... 2014 PuraMed BioScience ® , Inc., ... (OTC) medicinal and healthcare products, announced today that ... along with the name,s red and yellow logo. ... name MigraPure ®  going forward. The new ... natural migraine pain reliever will be reintroduced into ...
    (Date:7/30/2014)... DUBLIN , July 30, 2014 ... the "Global and Chinese Aseptic Packaging Industry Report ... http://photos.prnewswire.com/prnh/20130307/600769 The Global and ... in-depth study on the current state of the global ... situation. The report provides a basic overview of ...
    (Date:7/30/2014)... -- Stryker brand ambassadors Fred Funk and Hal ... Tour event near Minneapolis, MN , which begins ... Stryker is the official joint replacement products company of the PGA ... st through Sunday, August 3 rd , fans will be ... destination located in the Pioneer Press Expo tent located near the ...
    Breaking Medicine Technology:PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 2PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 3Global and Chinese Aseptic Packaging Industry Report 2014 2Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 2Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 3Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 4Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 5
    (Date:7/30/2014)... Hawley, Pennsylvania (PRWEB) July 30, 2014 ... and have contributed over $8,500 to ensure its protection. ... Resort, presents a check to the Delaware Highlands Conservancy ... Partnership program. The small $2-per-stay donations add up fast, ... future of the Upper Delaware River Region. , The ...
    (Date:7/30/2014)... West Orange, NJ. July 30, 2014. A new network ... the NIH Stroke Trials Network (NIH StrokeNet) is ... in the U.S. Despite advances of the last ... Each year, stroke causes death or disability for 795,000 ... the aging of the population. , To accelerate ...
    (Date:7/30/2014)... 2014 LTC Consumer, an independent, free online ... insurance, features an Instant Quote tool on its website, ... LTC Consumer. Quotes are free and unlimited. , The ... seven areas – including age, gender, and state of residence ... (you don’t need to enter any contact information to get ...
    (Date:7/30/2014)... July 30, 2014 The Institute for ... pleased to announce that Arianna Huffington has joined as a ... the Health Coach Training Program . , Arianna Huffington ... a world-renowned news and blogging site that won a Pulitzer ... of fourteen books and was included on the Forbes “Most ...
    (Date:7/30/2014)... 30, 2014 (HealthDay News) -- For patients with asthma, ... to trigger airway inflammation for at least 24 hours, ... you smell, but also what you think you smell," ... Senses Center in Philadelphia, said in a Monell news ... and fragrances. When we expect that an odor is ...
    Breaking Medicine News(10 mins):Health News:Pocono Mountain Resort Guests Contribute Over $8500 to Protect Land in 6 Short Months 2Health News:Kessler funded as satellite site for NIH Stroke Trials Network 2Health News:LTC Consumer Launches Online Tool for Getting Instant Long Term Care Insurance Estimates 2Health News:Arianna Huffington Joins Integrative Nutrition as a Guest Speaker 2Health News:Arianna Huffington Joins Integrative Nutrition as a Guest Speaker 3Health News:Even Thinking an Odor is Harmful May Spur Asthma Symptoms 2
    ... News) -- After reviewing more than 50,000 prescriptions for narcotic-containing ... that about 4 percent were given an overdose. ... study found. "Almost one in 10 of the youngest ... the dose that they should have received based on their ...
    ... media attention on young people being tormented by bullies and cyberbullies, ... The question they may want to ask instead is how can ... to be presented on Sunday, May 1, at the Pediatric Academic ... a key role in decreasing the chances that their son or ...
    ... jarring for a parent or caregiver to look in the ... the backseat free of their safety restraints. A study on ... most children who first unbuckle were age three and under ... motionputting them at a 3.5-fold increased risk for serious injuries. ...
    ... who care for patients with dementia now have a ... to a pilot study by a team of nurses. ... disease as well as periodontal disease," said Rita A. ... with the mouth. According to Jablonski, assistant professor of ...
    ... , SATURDAY, April 30 (HealthDay News) -- Aspirin,s ability to ... levels of fatty acids in the bloodstream, a new study ... a blood thinner for patients at high risk of a ... which plays a role in blood clot formation. It,s ...
    ... By Kathleen Doheny HealthDay Reporter , FRIDAY, April ... are commonly treated with surgery or surgery plus radiation, and ... about half. Now, researchers report that they have found ... to increase the risk of invasive breast cancers later. ...
    Cached Medicine News:Health News:Young Kids' Prescriptions Not Always on the Mark 2Health News:How to raise a child who doesn't bully 2Health News:Little fingers, big trouble: Yale study sheds light on child self-unbuckling 2Health News:Dirty mouths lead to broken hearts 2Health News:Breast Cancer Recurrence Rates Appear Different When Radiation Used 2
    The Achieva CV brings the power of CMR into routine clinical practice, so you can do more in Cardiovascular MR....
    The AutoSet Respond offers ResMeds unique AutoSet algorithm and product quality in a convenient, affordable model. The AutoSet algorithm responds to the patients pressure needs on a breath-by-breath ...
    ... Spirit is the premium APAP device in ... The AutoSet algorithm responds to the patients ... flow generator stores and reports comprehensive clinical ... AutoSet devices combine integrated humidification and a ...
    These products are primarily for use with paediatric patients and for patients with difficult veins....
    Medicine Products: